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Abstract 
Using a panel dataset on 45 sub-Saharan Africa countries (SSA), this study analyzes empirically 
the socioeconomic determinants of life expectancy gain (considered as an indicator of global 
health improvement at country level). In order to treat heterogeneity and endogeneity concerns, 
we use multiple estimation methods including pooling, fixed-effect, long difference and system 
GMM. Our analyses show that income is critical for health enhancement. Particularly, we find 
that GDP per capita is strongly and positively correlated with life expectancy gain. Furthermore, 
variables such as adult literacy, access to improved sanitation and safe water appear positively 
correlated health gain. In contrast the high incidence of extreme poverty is negatively correlated 
with heath gain while the impact of income inequality seems ambiguous. 
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1. Introduction 
Since the second half of the last century, the life expectancy1 has significantly increased in most 
of the developing countries, in particular, in Sub-Saharan Africa (SSA) where it went from 40.4 
years in 1960 to 54.16 years in 2010 (World Bank, 2010). As the debate has long existed about 
the causes of the mortality decline, many studies that investigate some possible explanations 
concerning the levels and the variation of life expectancy show mixed results. Various answers 
were given to the question of what factors has been most associated with the increases in levels 
of life expectancy. For some authors, this has been the result of the success in the application 
of communicable disease control technologies through public health activities (Stolnitz, 1975). 
And for others, it has been mainly attributable to the global improvement in the economic 
situation, particularly the elimination of famines and improved nutrition available to the people 
of the less developed countries (Krishnan, 1975).  
Despite these divergent views, these studies do not ignore the role that has been played by the 
conjunction of various socio-economic factors which resulted in an overall decrease in mortality 
risk over time. The improvement of health status observed in developing countries may have 
been also driven by the concomitant rises in economic levels, social well-being and health 
service investments through the increase in per capita income combined with higher health 
expenditure and progress in medical technologies. In this study, our analysis is focused 
essentially on those factors directly linked to the population living conditions such as income, 
poverty, inequality, education, social and environmental factors.  
Regarding number of studies carried out on the health problematic in developing countries, our 
study can be considered as an update of some of them although we take a different 
methodological step. In fact, authors like Kabir (2008) which examines the socio-economic 
determinants of life expectancy for 91 developing countries, uses probit regressions to 
determine the probability for a country to be in one of the following countries groups: low, 
medium and high life expectancy. As many of his explanatory variables turned out to be 
                                                          
1 Life expectancy at birth expresses the average length of time that an individual born in a given period would live 
if he experienced the mortality rates of that period throughout his lifetime. It indicates the number of years a 
newborn infant would live if prevailing patterns of mortality at the time of its birth is considered the same 
throughout its life. Life expectancy at birth provides a useful snapshot of mortality and represents a more synthetic 
measure of health status that is comparable across populations and time.  
In quantifying health status, life expectancy is, as for mortality rate, one of the most used traditional measures of 
global health. Although, recently other health indicators have been developed to represent not only death or living 
but also the condition of health. These indicators include the Disability Adjusted Life Year (DALY) and the 
Disability Adjusted Life Expectancy (DALE). But, these last indicators remain, in some respects, rarely used by 
researchers in large scales cross-country studies, given their very detailed data requirement. 
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statistically insignificant in most of his regressions, the author deduce that the relevant socio-
economic factors like per capita income, education, health expenditure, access to safe water, 
and urbanization cannot always be considered to be influential in determining life expectancy 
in developing countries. Also, Fayissa and Gutema (2005) estimate a health production function 
for Sub-Saharan Africa based on the Grossman (1972) theoretical model that treats social, 
economic, and environmental factors as inputs of health production function. Socioeconomic 
and environmental factors such as income per capita, illiteracy rate, food availability, ratio of 
health expenditure to GDP, urbanization rate, and carbon dioxide emission per worker are 
specified as determinants of health status. The model is estimated by one-way and two-way 
panel data approaches. Their results suggest that an increase respectively in income per capita, 
food availability and literacy rate are well associated with improvement in life expectancy. 
These results lead authors to suggest that health policy that focus solely on provision of program 
excluding socioeconomic aspects, may do little toward improving the current health status. 
But, the main criticism that could be addressed to these two previous studies is that, for the first, 
it does not exploits the temporal dimension allowing him to control for countries specificities 
by the use of panel methods. For the second study, the endogeneity issue of GDP per capita is 
not addressed. Hence, the accuracy of the estimations is seriously compromised. 
In this study, we use alternative approach to control potential estimation bias by exploiting both 
the temporal dimension and dealing with the endogeneity problem. Our dataset is a panel of 45 
countries which coverage span the period 1960-20112. For each variable, we have averaged 
over a five-year period the annual data to reduce annual fluctuations and measurement errors.  
The work is organized as follow. In Section 2, we proceed to the literature on recent empirical 
studies focusing on the determinants of health status particularly in developing countries. The 
third section is devoted to the presentation of data and descriptive statistics. In the fourth 
section, we develop the econometric model by proposing multiples estimation methods. This 
section is then accompanied by a fifth one in which we conduct diagnostic tests to assess the 
quality of our estimation methods. In the sixth section, we proceed to the presentation and the 
discussion of the estimation results followed by a general conclusion. 
 
 
                                                          
2 The list of the countries in the sample is presented in appendix. 
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2. Literature Review 
Country wealth is one of the most discussed health causal factor in the literature. It has long 
been evidenced a strong relation between health and the absolute level of income (measured by 
per capita GDP). It’s established that the lower per capita GDP, the lower life expectancy 
(World Bank, 1993). However, once countries attain some threshold level of income, the 
correlation between income and life expectancy become weak. Hence increases in per capita 
GDP no longer appear to be associated with life expectancy gains (Wilkinson, 1996). This 
author found that health of a population is directly related to its average income and no 
consistent relation is above that level.  Rogers (1979) which provided a conceptual framework 
of the relation between income and life expectancy based on the observations from developed 
countries found that the relation is non-linear. He observed that life expectancy rises at a 
declining rate as income grows. Education is also considered as one major influential 
determinant of life expectancy. Many studies have empirically demonstrated the dominant role 
of education in explaining the differences in health status. They highlight that life expectancy 
differs considerably in relation to education (Grabauskas and Kalediene, 2002; Kalediene and 
Petrauskiene, 2000).  But in general, few measures of education variables still be employed in 
the analyses of health status determinants. For example, Rogot et al (1992) revealed that life 
expectancy varies directly with years of schooling while Gulis (2000) which uses literacy rate 
shows statistically significant role of this variable in explaining life expectancy. 
Access to health care is considered as the most direct way of improving health status essentially 
through curative and preventive treatments including the provision of medical goods and 
facilities such as clean water, nutrition, mosquito (Gertler and van der Gaag, 1990). In a 
multivariate linear regression analysis on data of 156 countries, Gulis (2000) found that, access 
to safe drinking water impacts significantly life expectancy. However, the most used variables 
to test the effects of health inputs are typically the health resources indicators. These resources 
include health expenditure, health workforce (physician, nurse, etc.) and health infrastructure 
(hospital, and hospital beds, etc). The total health expenditure is perceived to have significant 
influence on life expectancy because it directly helps reduce mortality and morbidity (Kabir, 
2008).  Using cross-country time series data, Hitiris and Posnet (1992) find negative correlation 
between health spending and mortality rates. Grubaugh and Santerre (1994) find positive and 
significant impact of number of doctors and number hospital beds on infant mortality rates.  
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In addition to the previously determinants, other general characteristics of the population are 
considered among health determinants. Gender is one of these components. There is well-
known evidence that females live longer than males. Population behavior is another factor that 
affects heath status; for example, smoking, alcohol consumption, and daily activity. Phelps 
(1997) argued that the role of medical care is considerably small relative to the lifestyle. 
Urbanization also plays a crucial role in determining life expectancy. Although, Rogers and 
Wofford (1989) revealed that urbanization was less influential on life expectancy than 
anticipated, urban inhabitants of the developing countries generally enjoy improved medical 
care and means of life, better education, and other improved socio-economic facilities, which 
impact positively on health outcomes. 
Regarding the particular specificities of Sub-Saharan Africa region, we notice that the 
population of this region has been living under serious life-threatening diseases (malaria, 
diarrhoeal diseases, respiratory infections, AIDS, etc.), which have important implications for 
reduction in life expectancy. The SSA region also suffers from violent conflicts. Davis and 
Kuritsky (1997) found that, in countries experiencing severe conflicts, life expectancy has been 
shortened by an average 2.35 years. Since these geographical specificities tend to show an 
unfavorable context in SSA, it may be important to include in the analysis some of the aspects 
related to country epidemiologic and socioeconomic environment. 
3. Data and Sources 
 3.1. Sample  
The sample used in this study consists of 45 of the 47 SSA countries reported by the World 
Bank3 for which sufficient data are available over long period both for the life expectancy 
variable and the other interest variables. All the variables are extracted from the World 
Development Indicators database from which we compile a panel dataset covering the period 
1960-2011. The choice of 1960 as the base year is guided, in particular, by the idea that 1960 
is, for many SSA countries, a reference year marking their independence. Thus one may think 
that the observed evolution in life expectancy since this date can be considered as a good 
indicator of the progress realized by these countries in terms of health improvement.  
 
                                                          
3 http://go.worldbank.org/JRVQH9W970 
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3.2. Evolution of Life expectancy in SSA  
Since the second half of the last century, it has been observed a significant increase in life 
expectancy in the world. According to WPP (2010)4, over the five year-period 1950-1955, the 
average life expectancy at the world level was 48 years and it had reached 68 years by 2005-
2010. In 1950-55, the more developed regions already had a high expectation of life (66 years) 
and have since experienced further gains in longevity (76.9 years), 11 years higher than in the 
less developed regions where the expectation of life at birth is 65.9 years in 2005-10.  
When focusing on SSA countries where life expectancies are found to be among the lowest in 
the world, analysis of the dynamic of life expectancy in this region shows three major episodes 
in the evolution (Figure 1). Indeed, until the start of the 1990s, life expectancy has steadily 
increased from 40.49 years in 1960 to 49.53 years in 1989. From this year until 1996, it was 
observed a noticeable stagnation of the evolution of life expectancy. It was even observed a 
slight decrease until reaching almost 49.2 in 1996 (World Bank, WDI).  
Figure 1: Evolution of Life expectancy in SSA region from 1960 to 2010 
 
One of the main causes of life expectancy stagnation pointed out by numbers of studies has 
been of the explosion of HIV/AIDS epidemic. According to United Nation’ World Population 
Prospects (2010), life expectancy showed dramatic declines in the countries most affected by 
                                                          
4 United Nations, World Population prospects,2010 Revision 
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HIV/AIDS. In Botswana, for example,  where HIV prevalence was estimated at 24.8 percent in 
2009 (among  the aged 15-49 years), life expectancy has fallen from 64 years in 1985-90 to 49 
years in 2000-05. And for Southern Africa as a whole, where most of the worst affected 
countries are, life expectancy has fallen from 61 to 51 years over the last 20 years.  In addition 
to impact due to the AIDS epidemic, other factors have been identified as having contributed 
to the stagnation of life expectancy. These factors include armed conflict, economic stagnation, 
and resurgent infectious diseases such as tuberculosis and malaria.  
However, despite this significant stagnation, one can observe again, from the second half of 
1990, an increase of life expectancy which has reached 54.16 years in 2010. This recovery was 
mainly driven in part by the reduction of the magnitude of AIDS virus propagation in many 
countries, also due to the roles played by public health policies, which, for the most, are part of 
the MDG launched since the early 2000s. 
On gender aspects, it is widely recognized that female life expectancy at birth is higher than 
that of males in nearly all countries around the world. According to WPP (2010), females have 
a life expectancy of 70 years, compared to 66 years for males in 2010. The female advantage 
in the more developed regions is around 7 years while in the less developed regions, it’s almost 
3.5 years.  
In terms of longevity gain in Sub-Saharan Africa, despite non-monotonic evolution of life 
expectancy, the region has still made significant progress in terms of improvement in health 
status. Over the period 1960-2010, it recorded an absolute gain of 14 years (an increase of life 
expectancy of 33.8 percent compared to 1960 level). This represents an average of 2.7 years of 
longevity gain every 10 years (see table 1). 
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Table 1: Life expectancy gain in SSA compared to others regions (1960-2010) 
Region 1960 2010 
Absolute 
gain 
(years) 
Relative 
gain  
(%)  
Average 
decadal  
gain (years) 
By Geographic Area 
Sub-Saharan Africa  40.5 54.2 13.7 33.8 2.7 
East Asia and Pacific  47.6 73.2 25.7 54.0 5.1 
Europe and Central Asia  67.5 75.7 8.2 12.1 1.6 
European Union 69.4 79.7 10.3 14.8 2.1 
Latin America and Caribbean  56.1 74.1 18.0 32.1 3.6 
Middle East and North Africa  46.4 72.5 26.0 56.1 5.2 
North America 69.9 78.8 8.9 12.7 1.8 
South Asia 43.3 65.3 22.0 50.9 4.4 
By Income Level 
Low income 42.3 58.8 16.6 39.2 3.3 
Lower middle income 45.5 65.5 20.0 43.9 4.0 
Upper middle income 49.9 72.6 22.8 45.6 4.6 
OECD countries 67.5 79.4 11.9 17.7 2.4 
Sources: Calculations based on data from World Bank WDI 
 
Although Sub-Saharan Africa has experienced a significant gain in life expectancy over time, 
it has remained relatively less performing compared to other regions of the world such as 
Middle East and North Africa sub-region, East Asia and Pacific sub-region and South Asia, 
which have made respectively the gains of 56.1%, 54.0% and 50.9% compared to their initial 
level (see Table 1). 
4. Empirical Model  
Our empirical model departs from the following Cobb-Douglas health production function:  
𝐿𝐸𝑋𝑃𝑖𝑡 = (𝑆𝐸𝐿𝐶𝑖𝑡)
𝛽 ∗ (𝐻𝐼𝑖𝑡)
𝛾 ∗ (𝑒)𝛼+𝜇𝑖+𝜆𝑡+𝜀𝑖𝑡                                        (1. 𝑎) 
Where 𝐿𝐸𝑋𝑃𝑖𝑡 denotes the level of life expectancy in country 𝑖 at the time 𝑡. 𝑆𝐸𝐿𝐶𝑖𝑡 stands for 
all of socioeconomic factors related to living condition and 𝐻𝐼𝑖𝑡 captures the vector direct health 
inputs and any component of health system. The coefficients 𝛼, 𝛽 and 𝛾 represent the 
parameters to be estimated. 𝜇𝑖, 𝜆𝑡 and 𝜀𝑖𝑡 represent respectively the country-specific effect, 
time-specific effect and the error term. Taking the logarithm in equation (1.a) will yield the 
following Log-log functional form: 
𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) = 𝛼 + 𝛽𝑙𝑛(𝑆𝐸𝐿𝐶𝑖𝑡) + 𝛾𝑙𝑛(𝐻𝐼𝑖𝑡) + 𝜇𝑖 + 𝜆𝑡 + 𝜀𝑖𝑡          (1. 𝑏) 
Where the coefficients 𝛽 and 𝛾 can now be interpret as elasticities of life expectancy with 
respect of socioeconomics factors (𝑆𝐸𝐿𝐶𝑖𝑡) and direct health inputs (𝐻𝐼𝑖𝑡). 
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The variables incorporated in the analysis are the per capita GDP in purchasing power parity 
(PPP) dollar representing the per capita income. Although the per capita health expenditure is 
recognized as one of the key variable of health inputs, we have not included it in the regressions 
because of the acute problem of collinearity with income.  Nevertheless, we used the share of 
public health spending in total health expenditures. Since the major part of the health 
expenditures are endorsed by the government in developing countries, this indicator, 
representing, in fact, the public effort in health production, could serve to measure the impact 
and the effectiveness public spending on life expectancy. Still based on literature, we have also 
included the adult literacy, fertility rate, access to safe water and sanitation, number of 
physicians per thousand people. We control for country epidemiologic environment such as the 
prevalence of HIV (percentage of people living with HIV) and we also include variables related 
to socioeconomic environment such as incidence of extreme poverty (poverty headcount ratio 
at $1.25 PPP a day in % of population) and level of inequality represented by the gini index.  
4. Estimation Strategy 
4.1. Pooling and Fixed Effect Estimations 
Using equation (1.b), we first adopt the pooled cross-sectional regression model as our basic 
specification. In this estimation, all the individual observations on country and time period are 
pooled using five-year period average for life expectancy and explanatory variables. Assuming 
that the error term 𝜀 is stochastic and normally distributed with mean zero and constant 
variance, we first estimate equation (1.b) by Ordinary Least Squares (OLS). In this pooling 
estimation, one could control for country specific effect by including dummy variable for each 
country. But, given the high number of countries (45), introducing dummies variable would 
lead to a dummy variable trap, so we chose to control only for the time-effect by introducing 
time dummies which capture effects associated five-year periods we have constituted. The 
results obtained from this first estimation are presented in column 1 of Table 2. 
Although this OLS estimator remains unbiased and consistent if the error term does not contain 
any components that are correlated with explanatory, it may suffers from endogeneity problem 
of some explanatory variables. For instance, as there may be a strong reverse causality between 
health status and income, this will arise to the endogeneity problem that must be corrected using 
instrumental variable procedure. For that, we instrument GDP per capita following Pritchett 
and summers (1996). These authors, using results from Levine and Renelt (1992) and Easterly 
et al. (1993), used as instruments the terms-of-trade shocks and the ratio of investment to GDP. 
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Levine and Renelt (1992) showed that the ratio of investment to GDP is robustly related to 
growth. Easterly, Kremer, Pritchett, and summers (1993) have shown that the growth rates of 
income over five-year periods are explained in part by terms-of-trade shocks. This finding 
suggests us to use terms of trade shocks5 as an instrument, since the five-year changes in terms  
of  trade  are  convincingly  exogenous,  both  in the  sense  of  not having  a  direct  relation to 
health and  not  being  determined  by any  other  country-level  variable  that  jointly  affect  
income  growth  rates (Pritchett and Summers,1996).  Smith and Haddad (1999) also suggest 
the use of country economic openness as potential candidate for income instrumentation, as 
economic openness may improve national income but not otherwise directly affect health. 
Therefore, in complement of terms-of-trade shocks and ratio of investment to GDP, we use 
country openness measured as the ratio of trade volume (sum of imports and exports) to GDP. 
Results obtained from the 2SLS pooling estimations are presented in column 2 of Table 2. 
Trying to control for countries specific effects, we estimate fixed-effects model (Baltaji, 1995) 
which allows us to captures country-specific unobservables that may affect life expectancy and 
which do not vary over time. Time-invariant factors may be climatic conditions, countries’ 
physical environments and deeply-embedded cultural and social norms which can be controlled 
by 𝜇𝑖 in the estimations.  The fixed-effects approach, in addition to removing bias, can serve to 
control for measurement errors and non comparabilities in the data due to definitional and 
measurement differences at the country level (Ravallion and Chen 1996). Hence, in addition to 
previous time dummies (capturing time-specific effect), we introduce a single time-trend 
variable which can capture the long run effects of time such as those related to technological 
progress and innovations in medicine. The model is then estimated par the within approach 
whose results are summarized in column 3 and 4 of Table 2. 
 
 
 
 
                                                          
5 The terms of trade index measures the relative prices of a country's exports and imports. We use Net barter terms of trade 
index as term of trade indicator calculated as the percentage ratio of the export unit value indexes to the import unit value 
indexes (World Bank, WDI).. For each country, we estimate a deterministic trend, which is then extracted from the original 
series to get the cycle. This cyclical component (considered a deviation of the series compared to long-run equilibrium) is 
retained as our shock indicator since it’s highly affected by regular shocks (Perron, 1989). 
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Table 2: Pooling and fixed-effects estimations results 
     POOLED     WITHIN  
VARIABLES OLS 2SLS OLS 2SLS 
Gdp_pcapita 2.3e-06** 1.8e-05*** 1.2e-06** 3.7e-07 
 (0.021) (0.000) (0.037) (0.812) 
Share_Public_health_expenditure 0.008** 0.010** 0.018*** 0.019*** 
 (0.030) (0.036) (0.006) (0.007) 
Sanitary_access_rate 0.026*** 0.057* 0.015* -0.017 
 (0.003) (0.063) (0.090) (0.121) 
Safe_water_access_rate 0.070*** 0.134*** 0.047** 0.019** 
 (8.3e-04) (1.7e-04) (0.042) (0.047) 
Adult_literacy_rate 0.031** 0.022** 0.0018* 3.1e-05* 
 (0.048) (0.030) (0.089) (0.099) 
Fertility_rate 0.026 0.153** -0.229*** -0.243*** 
 (0.541) (0.0353) (4.7e-05) (2.1e-04) 
Urbanization _rate -0.015 -0.027** 0.051 0.089 
 (0.106) (0.0458) (0.143) (0.139) 
Physician_per_1000inhabt 0.012*** 0.007** 0.007** 0.003** 
 (0.001) (0.020) (0.028) (0.039) 
Prevalence_HIV -0.015*** -0.013** -0.014*** -0.008* 
 (1.3e-04) (0.0298) (3.6e-04) (0.058) 
Extreme_Poverty_headcount_ratio -0.079*** -0.074*** -0.050*** -0.041*** 
 (0.001) (1.9e-07) (1.7e-06) (2.0e-04) 
Gini_index 0.091 0.139* 0.059 0.027 
 (0.130) (0.0975) (0.213) (0.590) 
Constant 3.972*** 3.333*** 3.450*** 3.485*** 
 (8.1e-04) (6.9e-04) (2.3e-04) (8.1e-03) 
Time_trend no no yes yes 
Time dummies yes yes yes yes 
Sub-regions dummies yes yes yes yes 
Observations 271 271 271 225 
R-squared 0.718 0.432 0.547 0.539 
Prob F test that all u_i=0 0.000 0.000 
Prob Wald test corr( u_i, Xb)=0 0.000 0.000 
Pvalue in parentheses *** p<0.01, ** p<0.05, * p<0.1   
Sample: 1980-2010, Cf. section 5 for first stage regressions results    
 
4.3. Long-Difference Estimation 
As the annual or five-year change in life expectancy is very low, it seems more interesting to 
examine its evolution over a relatively long period in order to be able to identify the factors that 
can significantly contribute to the long-term variation. The aim of the long-difference 
estimation is to exploit the long-run changes in health status with respect to long-run changes 
in explanatory variables. In this approach, one suppose that the full effect of some of the 
explanatory variables can go beyond the just yearly or five-years changes in life expectancy. 
For example, health expenditure which is realized in a given year will continues to have effects 
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even in the subsequent years. In that case, rather than only associate expenditures with the 
corresponding life expectancy, one could analyze changes in life expectancy over a given period 
in relation to the absolute change in the interest variable over the same period. Thus, we estimate 
equation (1.b) in long differences (LD) approach following Acemoglu and Johnson (2005).   
The LD approaches make interpretation easier as they directly measure the effect of change in 
economic variables between two dates on the change in life expectancy between the same dates. 
This approach may be useful because it is less vulnerable to serial correlation problems in the 
error terms (Acemoglu and Johnson, 2005). This method may be just limited to two dates panel. 
For examples, the difference observed between 1980 and 1989, between 1990 and 2000 or 
between 2000 and 2010. Since we consider only two dates, this estimation procedure is 
equivalent to the first-differenced specification. Hence using equation (1.b), one can write the 
LD specification as follows: 
∆𝑡0𝑡1𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) = 𝛽∆𝑡0𝑡1𝑙𝑛(𝑆𝐸𝐿𝐶𝑖𝑡) + 𝛾∆𝑡0𝑡1𝑙𝑛(𝐻𝐼𝑖𝑡) +  ∆𝑡0𝑡1𝜆𝑡 + ∆𝑡0𝑡1𝜀𝑖𝑡                  (2. 𝑎) 
Where ∆𝑡0𝑡1𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) denotes the life expectancy gain in country 𝑖 determined as the absolute 
variation of the level of life expectancy between the two dates 𝑡0 and  𝑡1. ∆𝑡0𝑡1𝑙𝑛(𝑆𝐸𝐿𝐶𝑖𝑡) is 
the variation all of socioeconomic factors over the same period and  ∆𝑡0𝑡1𝑙𝑛(𝐻𝐼𝑖𝑡) the variation 
of the direct health inputs and others health system components. ∆𝑡0𝑡1𝜆𝑡 and ∆𝑡0𝑡1𝜀𝑖𝑡 represent 
respectively, time-varying factors and the error term. Note that in this specification, the country-
specific effect and the intercept term are just eliminated by the difference operator ∆ since these 
factors are supposed to be constants over time. But this is not necessarily the case for time-
specific since  ∆𝑡0𝑡1𝜆𝑡 can be different from zero. To control for this issue, we introduce the 
constant term in the difference equation6. The coefficient  𝛽 and 𝛾 represent the parameters to 
be estimated.  
Applying the difference operator on the logarithm elements, equation (2.a) can be rearranged 
and rewritten in terms of relative variation. Thus, we obtain the following equation (2.b): 
𝑙𝑛 (
𝐿𝐸𝑋𝑃𝑖𝑡1
𝐿𝐸𝑋𝑃𝑖𝑡0
) = 𝛽𝑙𝑛 (
𝑆𝐸𝐿𝐶𝑖𝑡1
𝑆𝐸𝐿𝐶𝑖𝑡0
) + 𝛾𝑙𝑛 (
𝐻𝐼𝑖𝑡1
𝐻𝐼𝑖𝑡0
) +  ∆𝑡0𝑡1𝜆𝑡 + ∆𝑡0𝑡1𝜀𝑖𝑡          (2. 𝑏) 
                                                          
6 As the constant is initially absent in this equation, introducing this variable will allows to capture the difference in the 
coefficients of the times dummies. This is easily mathematically demonstrable that this will be equivalent to ∆𝑡0𝑡1𝜆𝑡. 
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This equation is then estimated by 2SLS over three sub-periods and over the entire period. 
Table3 presents the results from these estimations. 
Table 3: Variation of Life expectancy  
 FIRST-DIFFERENCE 2SLS  
VARIABLES (1980-1989) (1990-1999) (2000-2010) (1980-2010) 
Gdp_pcapita  
 
-7.2e-06 2.4e-05** -2.3e-06 9.1e-06* 
 (0.149) (0.043) (0.183) (0.083) 
 Share_Public_health_expenditure  
 
0.126** 0.010** 2.2e-05* 0.068*** 
 (0.046) (0.017) (0.099) (0.005) 
Sanitary_access_rate 
 
1.330** -0.012 0.021 0.098** 
 (0.026) (0.596) (0.361) (0.016) 
Safe_water_access_rate  
 
2.771 -0.027 0.040* 0.148*** 
 (0.117) (0.547) (0.058) (0.003) 
Adult_literacy_rate 
 
-0.005 0.004* 0.018** 0.117** 
 (0.673) (0.078) (0.037) (0.011) 
Fertility_rate 
 
0.314*** -0.321** -0.095** -0.170** 
 (9.2e-04) (0.028) (0.044) (0.018) 
Urbanization _rate 
 
-0.025 0.090** 0.037 -6.4e-05* 
 (0.101) (0.018) (0.338) (0.099) 
Physician_per_1000inhabt  
 
6.3e-04 0.012*** 0.004* 0.012** 
 (0.886) (0.002) (0.060) (0.034) 
Prevalence_HIV  
 
---  
---  
 
-0.011** -0.004* -0.055*** 
 ---  
 
(0.030) (0.098) (3.8e-08) 
Extreme_Poverty_headcount_ratio  
 
-0.003 -0.027** 0.004 -0.060** 
 (0.637) (0.018) (0.817) (0.012) 
Gini_index  -0.010* 0.056** -0.028 0.117** 
 (0.082) (0.045) (0.536) (0.029) 
Constant for ∆𝑡0𝑡1𝜆𝑡 0.010*** -0.011** 0.038*** 0.022** 
 (2.0e-06) (0.039) (6.8e-07) (0.049) 
Sub-regions dummies yes yes yes yes 
Observations 45 45 45 45 
R-squared 0.786 0.565 0.589 0.722 
Pvalue in parentheses *** p<0.01, ** p<0.05, * p<0.1 
As Prevalence_HIV=0 for all countries between 1980-1989, thus this variable is dropped from  
 regressions for this period7.  
 
4.4. Dynamic Specification 
We also attempt to explore dynamic aspect of life expectancy by using standard dynamic 
models including lagged dependent variable as a regressor.  The dynamic specification is a way 
to overcome the weakness of the previous methods. Its specification is expressed as follow: 
                                                          
7 All the estimations previously done were made by assigning zero HIV prevalence over 1980-1989 for all countries since no 
HIV prevalence is observed during that period. And the HIV prevalence is rescaled using (+10-05) in logarithmic form. 
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𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) = 𝛼 + 𝛿𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡−1) + 𝛽𝑙𝑛(𝑆𝐸𝐿𝐶𝑖𝑡) + 𝛾𝑙𝑛(𝐻𝐼𝑖𝑡) + 𝜇𝑖 + 𝜆𝑡 + 𝜀𝑖𝑡                (3. 𝑎) 
Where 𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) and 𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡−1) are respectively the log of life expectancy at periods  𝑡  
and 𝑡 − 1. 𝑆𝐸𝐿𝐶𝑖𝑡 and 𝐻𝐼𝑖𝑡 are the other regressors. 𝜇𝑖, 𝜆𝑡 and 𝜀𝑖𝑡 represent respectively the 
country-specific effects, time-specific effects and the error term.  If  𝛿 ≠ 0, thus 𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) 
will be function of error term, and OLS estimation will be biased and inconsistent. Eliminating 
this bias requires, first, undertaking the short first-difference transformation to wipe out the 
country fixed-effect term. This yields the following estimating equation: 
∆𝑙𝑛(𝐿𝐸𝑋𝑃𝑖𝑡) = 𝛿𝑙𝑛(∆𝐿𝐸𝑋𝑃𝑖𝑡−1) + 𝛽𝑙𝑛(∆𝑆𝐸𝐿𝐶𝑖𝑡) + 𝛾𝑙𝑛(∆𝐻𝐼𝑖𝑡) + ∆𝜆𝑡 + ∆𝜀𝑖𝑡                  (3. 𝑏) 
To implement this estimation, we use a system of moment equations in system GMM approach 
(Blundell and Bond, 1998) in which we have two block of a stacked data organized in the form 
of system. The first block is built out of the data in level (equation 3.a) and the second of data 
in differences (equation 3.b). In this system, lagged variables in levels serve to instrument the 
differenced variables and lagged differences to instrument variable in levels.  
In panel data with a large number of cross-sections and a small number of time periods, the 
system GMM estimator has much smaller finite sample bias and is much more accurate in 
estimating autoregressive parameters. But one caveat of system GMM is that including 
excessive number of instruments dilutes the power of Hansen’s overidentification test and the 
test may falsely reject the null hypothesis that the instruments are valid8.  
In estimation, lagged life expectancy and per capita income are variables that are treated as 
endogenous and all of the estimations are performed by the two-step GMM. We check 
robustness of the model by using different time lags by changing the number of instruments in 
the system estimation.  The results from this estimations are presented in Table 4. 
 
 
 
 
 
                                                          
8  See Roodman (2008) for a discussion on the different problems which can arise by using too many instruments. 
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Table 4: Dynamic estimation results:  
    GMM estimation 
VARIABLES Coeff P.values 
Lag_ Life_expect 0.600*** (8.6e-07) 
Gdp_pcapita 1.1e-06** (0.015) 
Share_Public_health_expenditure 0.015*** (0.002) 
Sanitary_access_rate 0.014*** (0.008) 
Safe_water_access_rate 0.019** (0.026) 
Adult_literacy_rate 0.010** (0.027) 
Fertility_rate -2.3e-04 (0.996) 
Urbanization _rate 0.016 (0.121) 
Physician_per_1000inhabt 0.006** (0.017) 
Prevalence_HIV -0.009** (0.030) 
Extreme_Poverty_headcount_ratio -0.029* (0.074) 
Gini_index -0.008 (0.849) 
Constant 1.749*** (0.001) 
Time_trend yes    --- 
Time dummies yes    --- 
Sub-regions dummies yes    --- 
Observations 225    --- 
Number of instruments  38    --- 
Sargan test of overid.(Not robust, but not weakened by many instruments)  Prob > chi2 =  
0.033 Hansen test of overid(Robust, but weakened by many instruments.)             Prob >chi2 =   
0.096 Arellano-Bond test for AR(1) in first differences; H0:no serial correlation     Pr    >  z     =  
0.042 Arellano-Bond test for AR(2) in first differences; H0:no serial correlation     Pr    >  z     =  
0.191 Pvalue in parentheses *** p<0.01, ** p<0.05, * p<0.1 
 
5. Regressions diagnostics  
As the degree of robustness of an estimation can strongly dependent on several conditions, it is 
necessary to run some tests in order to assess the quality of our methods. 
After the test of presence of fixed effects, which strongly reject the hypothesis of absence of 
individual effects (bottom of Table 3) and thus justify the relevance of the use of panels in 
fixed-effects, the firsts set of tests we performed are those on instruments validity in 2SLS 
estimations. Presented in Table 6, results from the first stage estimations show that our three 
instruments are strongly correlated with GDP per capita (top of Table 6). The validity of these 
instruments is then tested through under-identification and weak identification tests which 
results are also presented. The under-identification test (Anderson, 1984), aims to test the rank 
condition of the matrix of the reduced form coefficients. To be valid, the instruments must 
satisfy the full rank condition meaning that the equation is identified and the excluded 
instruments are correlated with the endogenous regressor. Using Anderson canonical 
correlation between instruments and GDP per capita, one can reject the hypothesis of under-
identification at 1% level. 
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 Tabe 5: 2SLS estimation first stage results and instruments validity 
test Gdp_pcapita  
 
Coef. Std. Err.  t P>|t| 
Term_of_trade_shock 0.087 0.026 3.366 0.001 
Ratio_invest_gdp 0.038 0.014 2.661 0.008 
Trade_openness 0.193 0.091 2.124 0.035 
Control variables yes  ---  --- --- 
Number of obs  271       
Prob > F 0.000    
Centered R2 0.561       
Underidentification test 
Anderson canon. corr. LM statistic Chi-sq(3)=                  16.756                      P-val=                 
0.0008 Weak identification test 
Cragg-Donald Wald F stat= 8.87   H0 rejected according to Stock-Yogo  critical values for K1=1 and 
L1=3 Weak-instrument-robust inference 
Anderson-Rubin Wald test           Chi-sq(3)=                       32.90                       P-val=               
0.0000 Stock-Wright LM S statistic          Chi-sq(3)=                       29.34                       P-val=               
0.0000 Overidentification test 
Sargan statistic                             Chi-sq(2)=                       40.400                      P-val =              
0.0000  
Since the under-identification hypothesis is rejected, we test the weak identification hypothesis 
which arises when instruments are weakly correlated with the endogenous regressor. Using 
Cragg-Donald Wald F statistic and Stock-Yogo critical values table, one can also reject this 
hypothesis at 20% maximal IV relative bias and 25% maximal IV size which means that 2SLS 
estimator performs better than OLS estimator at these respective significance levels. 
The third diagnostic test is the Weak-instrument-robust inference which aims to test the 
significance of the endogenous regressor in the structural equation. It’s implemented by 
estimating the reduced form of the structural equation and testing joint nullity of excluded 
instruments coefficients. Using Anderson-Rubin (1949) and Stock-Wright (2000) tests statistics 
since both tests are robust to the presence of weak instruments, one can clearly reject at 1% 
level the hypothesis of joint nullity of the coefficient of excluded instruments in the reduced 
form. 
Although previous tests tend to relatively reinforce the credibility of the instruments, the Sargan 
over-identification test is less favorable since the results of this test reject the over-identification 
hypothesis in which the instruments are supposed to be uncorrelated with the error terms and 
properly excluded from the base equation. Rejection of this hypothesis leads us to doubt of the 
validity of the instruments. 
One of the main reasons that have led us to use dynamic estimation approach is the difficulty 
to find very credible instruments for GDP per capita. The GMM system approach estimation 
appears as one of the most robust methods providing the opportunity to get instruments directly 
from the variable itself using potential instruments available. The identification conditions are 
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mainly based on lags of independent variables. In estimation, we first checked for the robustness 
using different lags structures. For that, we depart from the AR test using Arellano-Bond 
autocorrelation test.  
The purpose of the Arellano-Bond autocorrelation test is to test the assumption that the error 
term in the levels equation are not autocorrelated. Given that the error term in the first-
difference equation has negative first-order autocorrelation, we cannot reject the hypothesis of 
absence of second order autocorrelation in the residuals of the first-difference equation. This 
means that we can choose our instruments between 2 and deeper lags periods. Hence, according 
to Arellano Bond AR test results and the rule of thumb that the number of instruments should 
be less than the number of groups (45), we finally retained between 2 and 3 lags periods in 
which we found that the estimated results still stable using only this interval. Also, our 
specification tests appear relatively satisfactory as the Hansen’s over-identifying restrictions 
are conclusive at 5 % level (see table 5). 
6. Discussion of results 
In most of our estimations, we find globally a positive effect of GDP per capita on life 
expectancy. In pooling approach (Table 2), the coefficient associated with this variable is 
positive and statistically significant at 5% level. We obtain the same results using panel fixed-
effects OLS estimation method although the coefficient loses significance in 2SLS estimation 
(Table 3). In the long difference method on 3 sub-periods (1980-1989, 1990-1999, 2000-2010), 
we find that the coefficient on income is significant only for 1990-1999 sub-period (Table 4) 
and thus in the entire period regression.  
Trying to treat properly the endogeneity problem of GDP per capita, we proceed to dynamic 
panel estimation where we instrument potential endogenous variables with their lagged values. 
The results obtained from this approach show positive and significant effect of income on at 
5% level (Table 5).  
Regarding variables directly related to the health system, we found that the share of public 
health expenditure has significant positive effect on life expectancy and this result is robust 
whatever the chosen estimation method. The number of physician per 1000 inhabitants also 
appears strongly correlated with life expectancy (See Table 2 to table 5).  
Turning to the other socioeconomic variables, we found that most of the selected variables 
impact significantly life expectancy. It appears that improved sanitation and safe water access 
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have positive and statistically significant impact on life expectancy (Table 3 through 5). Adult 
literacy rate is also positively and significantly correlated to higher life expectancy. The 
coefficient associated with variable is robustly significant in almost all of our regressions. 
Furthermore, our estimations results confirm those of earlier studies on the effect of the AIDS 
epidemic on life expectancy in sub-Saharan Africa countries. We found that the prevalence of 
HIV is significantly associated with low life expectancy. This result is significant at 1% in 
almost all of our estimations. As for the effect of poverty and inequality, the results show that 
poverty negatively influences life expectancy while the impact of inequality appears to be 
mixed. Indeed, globally we found a significant negative correlation between extreme poverty 
and life expectancy (Table 2 to Table 5) while the sign of the coefficient associated with the 
Gini index is very changing depending on the estimation method. In pooling, the coefficient is 
positive and significant at 10% in the 2SLS estimation. In the fixed-effect and dynamic panel 
method, this significance disappears. But, in the difference approach, we find that the 
coefficient is negative and significant for the period 1980-1989, positive and significant for 
1990-1999, but not significant for the period 2000-2010. This shows the difficulty to conclude 
any consistent effect of inequality on health status without a very thorough analysis of the 
relationship between the two variables. 
Conclusion 
In this paper, we have analyzed the impact of socioeconomic factors on life expectancy in SSA 
countries by applying different estimation methods which treat the problem heterogeneity 
between countries and deal with the endogenous nature of some of explanatory variables. For 
that, we used successively the pooling approach, the fixed-effect panel method, the difference 
method and particularly the system GMM approach to estimate the determinants of life 
expectancy considered as indicator global health status in a given country. In these estimations, 
we used a cross-country panel dataset from 45 SSA countries.  
The empirical results show that GDP per capita has statistically significant positive impact in 
enhancing health status. On the other hand, we found that the health system factors (captured 
by the share of government health spending and the number of physicians per 1000 inhabitants), 
strongly affect positively the life expectancy. Regarding other socioeconomic factors, we found 
that adult literacy and access to improved sanitation and safe water have positive and significant 
impact on health status. We also found that the prevalence of HIV has a strong negative impact 
on life expectancy. Furthermore, our estimations results show that extreme poverty appears 
19 
 
negatively correlated with life expectancy while the impact of inequality appears not conclusive 
given the changing sign and significance in most of our regressions.  
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Appendix 
List of countries in the sample 
Code Name Code Name 
AGO Angola MLI Mali 
BDI Burundi MOZ Mozambique 
BEN Benin MRT Mauritania 
BFA Burkina Faso MUS Mauritius 
BWA Botswana MWI Malawi 
CAF Central African Republic NAM Namibia 
CIV Cote d'Ivoire NER Niger 
CMR Cameroon NGA Nigeria 
COG Congo, Rep. RWA Rwanda 
CPV Cape Verde SDN Sudan 
DJI Djibouti SEN Senegal 
ERI Eritrea SLE Sierra Leone 
ETH Ethiopia SOM Somalia 
GAB Gabon SWZ Swaziland 
GHA Ghana TCD Chad 
GIN Guinea TGO Togo 
GMB Gambia, The TZA Tanzania 
GNB Guinea-Bissau UGA Uganda 
GNQ Equatorial Guinea ZAF South Africa 
KEN Kenya ZAR Congo, Dem. Rep. 
LBR Liberia ZMB Zambia 
LSO Lesotho ZWE Zimbabwe 
MDG Madagascar     
 
